250 related articles for article (PubMed ID: 6474626)
1. [Cytoplasmic androgen and estrogen receptor content in the tissues of human prostatic cancer].
Kushlinskiĭ NE; Bassalyk LS; Matveeva BP; Gorilovskiĭ LM; Degtiar' VG
Urol Nefrol (Mosk); 1984; (4):41-6. PubMed ID: 6474626
[No Abstract] [Full Text] [Related]
2. Human prostate steroid hormone receptor quantitation. Current methodology and possible utility as a clinical discriminant in carcinoma.
Shain SA; Boesel RW
Invest Urol; 1978 Nov; 16(3):169-74. PubMed ID: 361632
[No Abstract] [Full Text] [Related]
3. The role of estrogen, androgen and progestogen receptors in the management of carcinoma of the prostate.
Young JD; Sidh SM; Bashirelahi N
Trans Am Assoc Genitourin Surg; 1979; 71():23-5. PubMed ID: 545809
[TBL] [Abstract][Full Text] [Related]
4. A preliminary report on the measurement of cytosolic and nuclear prostatic tissue steroid receptors.
Olsson CA; deVere White R; Goldstein I; Traish AM; Müller RE; Wotiz HH
Prog Clin Biol Res; 1979; 33():209-21. PubMed ID: 93750
[No Abstract] [Full Text] [Related]
5. [Relationship between androgen and estrogen receptors and clinico-morphological characteristics of prostatic cancer].
Bassalyk LS; Petrova AS; Ermilova VD; Sokolova VK; Kushlinskiĭ NE
Arkh Patol; 1983; 45(2):23-8. PubMed ID: 6847409
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor assay in small biopsies of human prostate. Preservation of nuclear receptor from rat ventral prostate by lyophilization.
de Larminat MA; Scorticati C; Rennie PS; Bruchovsky N
Prog Clin Biol Res; 1984; 142():247-59. PubMed ID: 6200889
[No Abstract] [Full Text] [Related]
7. Inability of cytoplasmic or nuclear androgen receptor content or distribution to distinguish benign from carcinomatous human prostate.
Shain SA; Gorelic LS; Klipper RW; Ramzy I; Novicki DE; Radwin HM; Lamm DL
Cancer Res; 1983 Aug; 43(8):3691-5. PubMed ID: 6861139
[TBL] [Abstract][Full Text] [Related]
8. The application of steroid receptor assay in human prostate cancer research and clinical management (review).
Ekman P
Anticancer Res; 1982; 2(3):163-72. PubMed ID: 6751210
[No Abstract] [Full Text] [Related]
9. [Prostatic cytoplasmic androgen receptor in prostatic disease. II. Correlation between clinical response to hormonal therapy and change of R1881 receptor content in prostatic cancer during antiandrogenic therapy].
Kitano T
Nihon Hinyokika Gakkai Zasshi; 1984 Jul; 75(7):1098-108. PubMed ID: 6334193
[No Abstract] [Full Text] [Related]
10. [Androgen, progestin and estrogen receptors in the normal human prostate and in pathology].
Gerasimova TsI; Smirnov AN; Rozen VB; Buniatian AF; Bol'shakova TD
Sov Med; 1984; (6):32-6. PubMed ID: 6205454
[No Abstract] [Full Text] [Related]
11. Histochemistry of steroid receptors in prostatic diseases.
Pertschuk LP; Zava DT; Gaetjens E; Macchia RJ; Wise GJ; Kim DS; Brigati DJ
Ann Clin Lab Sci; 1979; 9(3):225-9. PubMed ID: 380450
[TBL] [Abstract][Full Text] [Related]
12. Steroid hormone receptors in prostatic hyperplasia and prostatic carcinoma.
Khalid BA; Nurshireen A; Rashidah M; Zainal BY; Roslan BA; Mahamooth Z
Med J Malaysia; 1990 Jun; 45(2):148-53. PubMed ID: 1725553
[TBL] [Abstract][Full Text] [Related]
13. Morphologic assay of steroid hormone receptors in human neoplasia.
Pertschuk LP; Tobin EH; Brigati DJ; Gaetjens E
Pathol Annu; 1980; 15(Pt 2):143-80. PubMed ID: 6161331
[No Abstract] [Full Text] [Related]
14. Measurement of androgen receptors in human prostatic tissue: methodological considerations.
Walsh PC; McLoughlin MG; Menon M; Tananis C
Prog Clin Biol Res; 1976; 6():159-68. PubMed ID: 1023206
[No Abstract] [Full Text] [Related]
15. Sucrose density gradient characterization of cytoplasmic [1,2-H3]-5alpha-dihydrotestosterone binding proteins in the accessory sexual glands of the male Syrian hamster.
Schmidt TJ; Visek WJ
J Steroid Biochem; 1978 Apr; 9(4):317-24. PubMed ID: 661313
[No Abstract] [Full Text] [Related]
16. [Importance of determining steroid hormone receptors and the treatment of prostatic cancer].
Fedotov IA; Denisov LE; Kozlov VP; Degtiar' VG
Urol Nefrol (Mosk); 1983; (1):63-70. PubMed ID: 6187115
[No Abstract] [Full Text] [Related]
17. Subcellular distribution of androgen receptors in human normal, benign hyperplastic, and malignant prostatic tissues: characterization of nuclear salt-resistant receptors.
Barrack ER; Bujnovszky P; Walsh PC
Cancer Res; 1983 Mar; 43(3):1107-16. PubMed ID: 6186370
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor assays in advanced prostatic cancer.
Buttyan R; Olsson CA
Urol Clin North Am; 1984 May; 11(2):311-7. PubMed ID: 6375068
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic value of the level of steroid hormone receptors in cancer of the large intestine].
Bassalyk LS; Korotkova TV; Prorokov VV; Murav'eva NI; Smirnova KD
Vopr Onkol; 1987; 33(9):43-6. PubMed ID: 3660756
[TBL] [Abstract][Full Text] [Related]
20. Adenocarcinoma of prostate: role of 17beta-estradiol and 5alpha-dihydrotestosterone binding proteins.
Sidh SM; Young JD; Karmi SA; Powder JR; Bashirelahi N
Urology; 1979 Jun; 13(6):597-603. PubMed ID: 452193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
